Home
Nuvalent, Inc.

Nuvalent, Inc. Market Share Analysis for August 2026

We respect the privacy of our website visitors and are committed to protecting visitors’ personal information.

Health > Biotechnology and Pharmaceuticals

Domainnuvalent.com

Year Founded2017

Employees51 - 200

Annual Revenue--

Nuvalent, Inc.

Nuvalent, Inc. (including company regionals)

nuvalent.com

See more website traffic and engagement information

Total visits to Nuvalent, Inc.'s top domains

Understand Nuvalent, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nuvalent.com24.9K

See more with Sales Intelligence

Avg. visit duration in Nuvalent, Inc.'s top domains

Analyze Nuvalent, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nuvalent.com00:00:45

See more with Sales Intelligence

Avg. pageviews on Nuvalent, Inc.'s top domains

See how Nuvalent, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nuvalent.com1.76

See more with Sales Intelligence

Nuvalent, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

nuvationbio.comCompany NameNuvation Bio, Inc.Employees51 - 200HQUnited States, New York, New YorkAnnual revenue$50M - $75MTotal visits17KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Nuvalent, Inc.

These are the website technologies, by industry, used by Nuvalent, Inc. top domains

Payment & Currencies (10)

Cart Functionality

Advertising (6)

DoubleClick

eCommerce (5)

OpenCart

Content Management System (4)

WordPress

More Technologies

13

See all

News & Signals from Nuvalent, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNuvalent, Inc. is developing companion diagnostics.The company also announced a collaboration with Nuvalent to develop companion diagnostics, initially focused on Guardant360 Tissue.

NewsNuvalent, Inc. had issues with possible breaches of fiduciary duty and other violations of law on Jul 2nd '26.MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) - Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc.

NewsGlaxoSmithKline was planning to acquire Nuvalent, Inc. for $10.6B on Jun 9th '26.British pharmaceutical group GSK said today it had agreed to buy Nuvalent, a Boston-based company focused on cancer treatments, for US$10.6 billion.